Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Thermo Fisher Scientific    TMO

THERMO FISHER SCIENTIFIC

(TMO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Thermo Fisher Scientific : The technical configuration is positive

share with twitter share with LinkedIn share with facebook
10/01/2020 | 03:55am EDT
long trade
Live
Entry price : 445.97$ | Target : 525$ | Stop-loss : 400$ | Potential : 17.72%
Shares in Thermo Fisher Scientific do not show any sign of a slowdown in the ascending dynamic. Investors could bet on a continuation of the underlying trend.
Investors have an opportunity to buy the stock and target the $ 525.
Thermo Fisher Scientific : Thermo Fisher Scientific : The technical configuration is positive
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
  • In a short-term perspective, the company has interesting fundamentals.

Strengths
  • The group's high margin levels account for strong profits.
  • There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
  • Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • For the past twelve months, EPS forecast has been revised upwards.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The tendency within the weekly time frame is positive above the technical support level at 350.95 USD

Weaknesses
  • Based on current prices, the company has particularly high valuation levels.
  • The firm trades with high earnings multiples: 36.98 times its 2020 earnings per share.
  • The company is not the most generous with respect to shareholders' compensation.
  • For the past seven days, analysts have been lowering their EPS expectations for the company.
Ratings chart
Subsector Advanced Medical Equipment & Technology - NEC
1st jan.Capitalization (M$)Investor Rating
THERMO FISHER SCIENTIFIC47.99%193 562
DANAHER CORPORATION52.95%170 334
INTUITIVE SURGICAL, INC.17.00%84 746
SHENZHEN MINDRAY BIO-MEDICA..99.41%65 761
BOSTON SCIENTIFIC CORPORATI..-20.28%51 576
SIEMENS HEALTHINEERS AG-12.07%47 693
EDWARDS LIFESCIENCES CORPOR..-4.94%47 678
ILLUMINA, INC.-5.68%47 090
KONINKLIJKE PHILIPS N.V.-5.66%44 909
AGILENT TECHNOLOGIES, INC.20.58%32 693
RESMED, INC.16.77%26 786
More Results


share with twitter share with LinkedIn share with facebook

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials (USD)
Sales 2020 30 615 M - -
Net income 2020 5 799 M - -
Net Debt 2020 12 098 M - -
P/E ratio 2020 33,5x
Yield 2020 0,17%
Capitalization 194 B 194 B -
EV / Sales 2020 6,72x
EV / Sales 2021 6,17x
Nbr of Employees 75 000
Free-Float 90,6%
Upcoming event on THERMO FISHER SCIENTIFIC
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 21
Average target price 501,65 $
Last Close Price 489,30 $
Spread / Highest target 12,4%
Spread / Average Target 2,52%
Spread / Lowest Target -21,5%
EPS Revisions
Managers
NameTitle
Marc N. Casper Chairman, President & Chief Executive Officer
Mark P. Stevenson Chief Operating Officer & Executive Vice President
Stephen Williamson Chief Financial Officer & Senior Vice President
Ryan Snyder Chief Information Officer & Senior Vice President
Scott M. Sperling Independent Director